We make Clinical Research faster
and more successful
We simplify clinical trials and support Biotech companies, Medical Device innovators, Non-profits, and Academic institutions with innovative solutions and high-impact research services.
Why choose us?
Leveraging our own cutting-edge technology, risk-based processes, and data-driven strategies we bring your product to market faster, boosting revenue and making it easier to scale quickly.
Our Solutions
Comprehensive support throughout every stage of a clinical study involving drugs and medical devices.
Study Preparation
Is your clinical study not ready to start yet?
We take care of the clinical study setup, putting all the regulatory and organizational foundations in place to ensure a compliant start.
Study Start-Up
Are approvals and site activation delaying the start of your clinical study?
We manage the authorization process, site activation, and contracts to help you enroll your first patients on schedule.
Study Conduct
Is your clinical study underway, but becoming difficult to keep under control?
Through clinical monitoring and data management, we help you maintain compliance and ensure study quality.
Study Close-Out
Do you want to bring your study to a smooth and structured conclusion?
We manage study close-out, statistical analysis, and the preparation of the final clinical study report, providing complete documentation for submission of the results to the relevant authorities.
55+
Clinical Trials
600 +
Investigators
300+
Hospitals
16k+
Patients
Clinical Research News
Latest News in Clinical Research
Explore our latest articles to stay updated on the innovations, methodologies, and discoveries in the world of clinical trials. Delve into the topics that are shaping the future of clinical research.
-

eCRF Data Entry Delays: A Compliance Risk Frequently Underestimated
There is a scenario that everyone working in clinical research knows well. The site is under pressure, priorities keep shifting, and the electronic Case Report Form — which should reflect the real-time status of the study — stops being updated. The data exists: it is in the source documents, often correctly recorded. But it does…
-

PMCF under MDR: from regulatory obligation to competitive advantage
In many medical device companies, Post-Market Clinical Follow-up (PMCF) is still seen as a burden — a bureaucratic requirement introduced by the EU MDR (EU 2017/745) that adds cost and pressure to already overloaded regulatory teams. That view is increasingly short-sighted.Companies that treat PMCF purely as compliance are missing a significant strategic opportunity. The MDR…
Do you have something in mind?
Let’s talk about how we can support your next clinical trial.
Request a quotation to our experts.